Kaleido Biosciences Inc (KLDO) stock has gained 21.73% over the past week and gets a Bullish rating from InvestorsObserver's Sentiment Indicator.
What is Stock Sentiment?
When making investment decisions, sentiment gives a good overview of what stocks investors currently favor. Sentiment incorporates short-term technical analysis into its score and does not encompass any fundamental analysis such as profitability of the company. This means that earnings updates and other news can greatly impact overall sentiment.
Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish.
InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion.
For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.
What's Happening With KLDO Stock Today?
Kaleido Biosciences Inc (KLDO) stock is trading at $7.62 as of 11:59 AM on Monday, Aug 10, a gain of $0.84, or 12.48% from the previous closing price of $6.77. The stock has traded between $7.07 and $8.05 so far today. Volume today is above average. So far 347,677 shares have traded compared to average volume of 151,488 shares.
To screen for more stocks like Kaleido Biosciences Inc click here.
More About Kaleido Biosciences Inc
Kaleido Biosciences Inc is a clinical-stage healthcare company. It is focused on leveraging the potential of the microbiome organ to treat disease and improve human health. Its product candidates are Microbiome Metabolic Therapies, or MMTs, which are designed to modulate the metabolic output and profile of the microbiome.
